karl morten

Using Single-Cell Raman Microspectroscopy to Profile Human Peripheral Blood Mononuclear Cells Elizabeth Gan, Megan Stoker, Edie Guo, Karl J. Morten & Jiabao Xu [Line break added] Abstract A reliable, validated test would enhance our ability to treat and research chronic conditions. Early and...

Preprint. Paper now published, see this post Abstract A blood-based diagnostic test for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and multiple sclerosis (MS) would be of great value in both conditions, facilitating more accurate and earlier diagnosis, helping with current...

Full title: Diagnosis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome With Partial Least Squares Discriminant Analysis: Relevance of Blood Extracellular Vesicles Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), a chronic disease characterized by long-lasting persistent...

"THIS EVENT IS ONLINE ONLY. It will be held on Zoom, hosted by OMEGA. You will be sent a link to the meeting shortly before the start time to the email address you sign up with. This event is FREE. Any enquiries, please email enquire.omega@gmail.com. OMEGA is a support group for people with ME...

Relationship between Cardiopulmonary, Mitochondrial and Autonomic Nervous System Function Improvement after an Individualised Activity Programme upon Chronic Fatigue Syndrome Patients Katarzyna Buszko Sławomir Kujawski Jo Cossington Joanna Słomko Monika Zawadka-Kunikowska Małgorzata...

Open access, https://www.mdpi.com/2077-0383/9/8/2531

Morning coffee break has found this on twitter. As a relative newbie things always surprise me - has this not been done before?

Open access to PDF, https://www.mdpi.com/2076-3425/10/1/4 Note: Fukuda selection criteria. ETA: I was conflicted whether this should go in the Biomedical or the Psychosocial sub-forum as, to my mind, there are elements of both about it.

Most talks aren't directly related to ME, but Karl Morten's talk is titled "Plasma Metabolomics in ME/CFS: a tale of two cohorts.". Also possibly of interest is Bhupesh Prusty, whose talk is titled "Mitochondrial architecture decides the niche for pathogenic survival."...

If I've understood........Dr Myhills test doesn't work. full paper here https://www.nature.com/articles/s41598-019-47966-z

So, for those of you who aren't aware, I have been fortunate enough to be invited along to take part in these meetings as a patient representative. A brief overview of Dr Morten can be found here, https://www.wrh.ox.ac.uk/team/karl-morten, and his MEpedia page is...

https://nationaldiversityawards.co.uk/nominate/22663/ As far as I can see, the tweet refers to voting but it's actually nominating Jamie, so there is a little more effort required in that you need to explain why you are nominating him.

@Jonathan Edwards, I remember that in the other place several of us had a long discussion about what could explain the two peaks in onset-age for ME/CFS. I just saw the graph that we were discussing reproduced in Slide #25 of Karl Morten's recent talk in NZ...

The UK biobank have shared samples with Karl Morten at Oxford University to look for metabolites & other chemical clues. http://cureme.lshtm.ac.uk/biobank-samples-received-dr-karl-morten/

http://pubs.rsc.org/en/Content/ArticleLanding/2018/AN/C8AN01437J#!divAbstract

The ME Association has been working for some time with Dr Karl Morten and the research team at Oxford who have recently been honing their approach to the study of metabolomics in ME/CFS. Before embarking on a new study utilising samples from the ME/CFS Biobank for the ME Association, they have...